• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白颗粒浓度和大小可预测1型糖尿病患者发生冠状动脉疾病事件的风险。

HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.

作者信息

Costacou Tina, Vaisar Tomas, Miller Rachel G, Davidson W Sean, Heinecke Jay W, Orchard Trevor J, Bornfeldt Karin E

机构信息

Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261.

Department of Medicine, University of Washington, Seattle, WA 98109.

出版信息

medRxiv. 2023 Nov 7:2023.11.06.23298165. doi: 10.1101/2023.11.06.23298165.

DOI:10.1101/2023.11.06.23298165
PMID:37986833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10659494/
Abstract

BACKGROUND

Cholesterol efflux capacity (CEC) negatively correlates with cardiovascular disease risk. Small HDL particles account almost quantitively for CEC, perhaps mediated through efflux of outer leaflet plasma membrane phospholipids by ABCA1. People with type 1 diabetes (T1D) are at increased risk of coronary artery disease (CAD) despite normal levels of HDL-cholesterol (HDL-C). We therefore tested the hypotheses that small HDL particles (HDL-P)-rather than HDL-C levels-predict incident CAD in T1D.

METHODS

Incident CAD (CAD death, myocardial infarction, and/or coronary revascularization) was determined in a cohort of 550 participants with childhood-onset T1D. HDL-P was quantified by calibrated ion mobility analysis. CEC and phospholipid efflux were quantified with validated assays.

RESULTS

During a median follow-up of 26 years, 36.5% of the participants developed incident CAD. In multivariable Cox models, levels of HDL-C and apolipoprotein A-I (APOA1) did not predict CAD risk. In contrast, extra-small HDL particle levels strongly and negatively predicted risk (hazard ratio [HR]=0.25, 95% confidence interval [CI]=0.13-0.49). An increased concentration of total HDL particles (T-HDL-P) (HR=0.87, CI=0.82-0.92) and three other HDL sizes were weaker predictors of risk: small HDL (HR=0.80, 0.65-0.98), medium HDL (HR=0.78, CI=0.70-0.87) and large HDL (HR=0.72, CI=0.59-0.89). Although CEC negatively associated with incident CAD, that association disappeared after the model was adjusted for T-HDL-P. Isolated small HDLs strongly promoted ABCA1-dependent efflux of membrane outer leaflet phospholipids.

CONCLUSIONS

Low concentrations of T-HDL-P and all four sizes of HDL subpopulations predicted incident CAD independently of HDL-C, APOA1, and other common CVD risk factors. Extra-small HDL was a much stronger predictor of risk than the other HDLs. Our data are consistent with the proposal that small HDLs play a critical role in cardioprotection in T1D, which might be mediated by macrophage plasma membrane outer leaflet phospholipid export and cholesterol efflux by the ABCA1 pathway.

摘要

背景

胆固醇流出能力(CEC)与心血管疾病风险呈负相关。小HDL颗粒几乎定量地决定了CEC,这可能是通过ABCA1介导的质膜外层小叶磷脂流出实现的。1型糖尿病(T1D)患者尽管HDL胆固醇(HDL-C)水平正常,但患冠状动脉疾病(CAD)的风险增加。因此,我们检验了以下假设:在T1D中,是小HDL颗粒(HDL-P)而非HDL-C水平预测CAD的发生。

方法

在一个550名儿童期发病的T1D参与者队列中确定CAD的发生情况(CAD死亡、心肌梗死和/或冠状动脉血运重建)。通过校准离子迁移率分析对HDL-P进行定量。用经过验证的检测方法对CEC和磷脂流出进行定量。

结果

在中位随访26年期间,36.5%的参与者发生了CAD。在多变量Cox模型中,HDL-C和载脂蛋白A-I(APOA1)水平不能预测CAD风险。相比之下,超小HDL颗粒水平强烈且负向预测风险(风险比[HR]=0.25,95%置信区间[CI]=0.13 - 0.49)。总HDL颗粒(T-HDL-P)浓度增加(HR=0.87,CI=0.82 - 0.92)以及其他三种HDL大小是较弱的风险预测指标:小HDL(HR=0.80,0.65 - 0.98)、中HDL(HR=0.78,CI=0.70 - 0.87)和大HDL(HR=0.72,CI=0.59 - 0.89)。尽管CEC与CAD的发生呈负相关,但在模型校正T-HDL-P后,这种关联消失了。分离出的小HDL强烈促进ABCA1依赖的膜外层小叶磷脂流出。

结论

低浓度的T-HDL-P以及所有四种大小的HDL亚群独立于HDL-C、APOA1和其他常见的心血管疾病风险因素预测CAD的发生。超小HDL是比其他HDL更强的风险预测指标。我们的数据与以下观点一致,即小HDL在T1D的心脏保护中起关键作用,这可能是由巨噬细胞质膜外层小叶磷脂输出和通过ABCA1途径的胆固醇流出介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7525/10659494/4696c85d6bb0/nihpp-2023.11.06.23298165v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7525/10659494/9f8d81949118/nihpp-2023.11.06.23298165v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7525/10659494/4696c85d6bb0/nihpp-2023.11.06.23298165v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7525/10659494/9f8d81949118/nihpp-2023.11.06.23298165v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7525/10659494/4696c85d6bb0/nihpp-2023.11.06.23298165v1-f0002.jpg

相似文献

1
HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.高密度脂蛋白颗粒浓度和大小可预测1型糖尿病患者发生冠状动脉疾病事件的风险。
medRxiv. 2023 Nov 7:2023.11.06.23298165. doi: 10.1101/2023.11.06.23298165.
2
High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.高密度脂蛋白颗粒浓度和大小可预测 1 型糖尿病患者发生冠心病事件的风险。
J Am Heart Assoc. 2024 Jul 16;13(14):e034763. doi: 10.1161/JAHA.123.034763. Epub 2024 Jul 3.
3
Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study.1 型糖尿病患者中高密度脂蛋白颗粒浓度和胆固醇流出能力与新发冠状动脉疾病的相关性的性别差异:RETO HDLc 队列研究。
J Clin Lipidol. 2024 Mar-Apr;18(2):e218-e229. doi: 10.1016/j.jacl.2024.01.004. Epub 2024 Jan 29.
4
Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.载脂蛋白 A1 C 端翻转促进小高密度脂蛋白依赖 ABCA1 的胆固醇外流。
Circulation. 2024 Mar 5;149(10):774-787. doi: 10.1161/CIRCULATIONAHA.123.065959. Epub 2023 Nov 29.
5
Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs.载脂蛋白A1翻转的C末端通过小高密度脂蛋白促进ABCA1依赖性胆固醇外流。
medRxiv. 2023 Nov 4:2023.11.03.23297986. doi: 10.1101/2023.11.03.23297986.
6
Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.糖尿病损害细胞内胆固醇从ABCA1向小HDL颗粒的流出。
Circ Res. 2020 Oct 9;127(9):1198-1210. doi: 10.1161/CIRCRESAHA.120.317178. Epub 2020 Aug 21.
7
HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.1 型糖尿病患者的高密度脂蛋白颗粒大小增加,高密度脂蛋白胆固醇流出增强:一项横断面研究。
Diabetologia. 2021 Mar;64(3):656-667. doi: 10.1007/s00125-020-05320-3. Epub 2020 Nov 9.
8
Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.无细胞、高密度脂蛋白特异性磷脂外排测定预测心血管疾病事件的发生。
J Clin Invest. 2023 Sep 15;133(18):e165370. doi: 10.1172/JCI165370.
9
Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.载脂蛋白 AI 对冠心病患者的预测价值:与冠状动脉斑块特征及临床事件的关系。
Ann Med. 2022 Dec;54(1):1036-1046. doi: 10.1080/07853890.2022.2063374.
10
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).胆固醇流出能力、高密度脂蛋白颗粒数量与心血管事件发生率:来自JUPITER试验(他汀类药物在预防中的应用依据:一项评估瑞舒伐他汀的干预试验)的分析
Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27.

本文引用的文献

1
Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.载脂蛋白 A1 C 端翻转促进小高密度脂蛋白依赖 ABCA1 的胆固醇外流。
Circulation. 2024 Mar 5;149(10):774-787. doi: 10.1161/CIRCULATIONAHA.123.065959. Epub 2023 Nov 29.
2
Size matters: HDL particle populations and the risk of infection.大小很重要:高密度脂蛋白颗粒群体与感染风险
Nat Rev Cardiol. 2023 May;20(5):279-280. doi: 10.1038/s41569-023-00844-8.
3
ABCA1 is an extracellular phospholipid translocase.ABCA1 是一种细胞外磷脂转运蛋白。
Nat Commun. 2022 Aug 16;13(1):4812. doi: 10.1038/s41467-022-32437-3.
4
Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships.在大规模流行病学中对综合脂蛋白数据的恰当解读:揭示基本的结构和代谢关系。
Int J Epidemiol. 2022 Jun 13;51(3):996-1011. doi: 10.1093/ije/dyab156.
5
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.载脂蛋白 A-I 减少缺血性综合征事件研究 II(AEGIS-II)的原理和设计:一项 3 期、多中心、双盲、随机、安慰剂对照、平行组研究,旨在评估 CSL112 在急性心肌梗死后患者中的疗效和安全性。
Am Heart J. 2021 Jan;231:121-127. doi: 10.1016/j.ahj.2020.10.052. Epub 2020 Oct 13.
6
Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.糖尿病损害细胞内胆固醇从ABCA1向小HDL颗粒的流出。
Circ Res. 2020 Oct 9;127(9):1198-1210. doi: 10.1161/CIRCRESAHA.120.317178. Epub 2020 Aug 21.
7
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.大颗粒高密度脂蛋白浓度升高及高密度脂蛋白对氧磷酶 1 含量增加与长期 1 型糖尿病患者血管并发症的保护相关。
Diabetes Care. 2020 Jan;43(1):178-186. doi: 10.2337/dc19-0772. Epub 2019 Oct 9.
8
The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.携氧蛋白 2-2 基因型与 1 型糖尿病心脏自主神经病变相关:RETRACT-HDLC 研究。
Acta Diabetol. 2020 Mar;57(3):271-278. doi: 10.1007/s00592-019-01422-6. Epub 2019 Sep 16.
9
Is ABCA1 a lipid transfer protein?ABCA1 是否为脂质转运蛋白?
J Lipid Res. 2018 May;59(5):749-763. doi: 10.1194/jlr.R082313. Epub 2018 Jan 5.
10
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).胆固醇流出能力、高密度脂蛋白颗粒数量与心血管事件发生率:来自JUPITER试验(他汀类药物在预防中的应用依据:一项评估瑞舒伐他汀的干预试验)的分析
Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27.